Astrocytes with high GFAP expression, including disease-associated astrocytes, have been mostly reported to expand in AD and play a role in neuroinflammation, metabolic dysregulation, and blood–brain barrier dysfunction [103, 106, 107]. The gene discussed is GFAP; the disease is Alzheimer disease.